A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 95.89
GOOG 699.21
MSFT 51.16
FB 114.19
BAC 13.10

Recently Added

WNC 12.71
SUNEQ 0.15
CIX 11.29
ZBH 120.68
SPHS 2.17

Gaining Speed

WNC 12.71
SUNEQ 0.15
EXAS 12.31
VG 5.90
AAPL 95.89

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!